SREBP-1C is one of the major transcriptional factors involved in de novo lipid synthesis, which affects NAFLD through the nuclear transcription factor farnesoid X receptor (FXR) [41]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.